VC-backed BlueRock Therapeutics adds Kovacs to C-suite team
Toronto, New York and Cambridge, Massachusetts-based BlueRock Therapeutics LP, a cell therapy company, has appointed Shane Kovacs as both chief business and chief financial officer. Previously, he was managing director and head of biotechnology investment banking at RBC Capital Markets in New York. BlueRock was backed by Bayer AG and Versant Ventures.
20 September 2018•3 mins read
